Clinical Trials Directory

Trials / Completed

CompletedNCT02650141

Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty

Efficacy of Experienced Chinese Herbal Formulas for the Treatment of Different Types of Precocious Puberty: A Single-blinded Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
143 (actual)
Sponsor
Children's Hospital of Fudan University · Academic / Other
Sex
Female
Age
8 Years
Healthy volunteers
Not accepted

Summary

Due to various complex factors, the incidence of precocious puberty is increasing rapidly. It severely threatens physical and mental health of children. It's urgent to explore effective ways to control the disease.

Detailed description

In the research, 138 precocious puberty children are randomly divided into the Ziyinxiehuo granules group (69 cases) and Zishenqinggan granules group(69 cases). Patients in Ziyinxiehuo granules group are treated with a series of experienced chinese herbal formulas, whereas the Zishenqinggan granules group received with different series of experienced chinese herbal formulas.

Conditions

Interventions

TypeNameDescription
DRUGziyinxiehuo GranulesZiyinxiehuo granules Herbs (1 bag ): shengdi 5g, xuanshen 3g, zexie 3g, zhimu3g, huangpai 3g, zhiguiban 2g, maiya 6g,tiandong 3g, zhigancao 2g Therapeutic Principle: Nourishing "Yin", removing "Fire" Usage: administered after dissolved, 3 times per day after breakfast and supper
DRUGzishenqinggan GranulesZishenqinggan granules Herbs (1 bag ): Shengdi 5g, baishao 3g, huangqin 3g, fuling 4g, danpi 3g, maiya 6g, shanzha 3g, zhebei 3g, zhigancao 2g Therapeutic Principle: replenishing "Kidney", Clearing "Liver" Usage: administered after dissolved, 3 times per day after breakfast and supper

Timeline

Start date
2013-04-01
Primary completion
2015-11-01
Completion
2016-04-01
First posted
2016-01-08
Last updated
2019-12-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02650141. Inclusion in this directory is not an endorsement.